Immune Microenvironment on the Molecular Mechanisms and Therapeutic Targets of MAFLD

Area of Science:

• Hepatology
• Immunology
• Gastroenterology

Background:

• Metabolic dysfunction-associated fatty liver disease (MAFLD) is a global health issue characterized by liver fat accumulation.
• MAFLD can advance to severe liver conditions like fibrosis, cirrhosis, and hepatocellular carcinoma (HCC).
• Current treatments for MAFLD are limited, with a need for therapies targeting its core mechanisms.

Purpose of the Study:

• To examine the molecular mechanisms of the immune microenvironment in MAFLD.
• To identify potential therapeutic targets within the immune system for MAFLD treatment.
• To provide insights for future clinical and scientific advancements in MAFLD immunotherapy.

Main Methods:

• Literature review focusing on molecular mechanisms of the immune microenvironment in MAFLD.
• Analysis of recent studies on immune cell involvement and signaling pathways in MAFLD pathogenesis.
• Identification of potential immune targets based on current research findings.

Main Results:

• The liver's immune microenvironment plays a crucial role in MAFLD onset and progression.
• Specific immune cells and molecular pathways are implicated in MAFLD pathogenesis.
• A gap exists in understanding specific immune targets and developing targeted immunotherapies for MAFLD.

Conclusions:

• Targeting the immune microenvironment holds promise for novel MAFLD therapies.
• Further research is needed to fully elucidate immune mechanisms and identify actionable therapeutic targets.
• This review highlights the potential for immune-based strategies to combat MAFLD progression and improve patient outcomes.